The rapid increase in neurological disorders, increase in geriatric population, and continuous increase in the number of patients are fueling the market growth.
Market Size – USD 9.43 Billion in 2018, Market Growth - CAGR of 6.3%, Market Trends – Rise in autoimmune diseases.
The Global Intravenous Immunoglobulin (IVIG) Market is forecast to reach USD 15.67 Billion by 2026, according to a new report by Reports and Data.
Immunoglobulin refers to the breakdown of blood plasma that contains antibody. It is a procedure that is undertaken intravenously. It is a treatment of choice for patients with antibody deficiency. Immunoglobulins are highly complex entities, and they are very specific in their action. They are obtained from blood by fractionation process and purified for nontherapeutic and therapeutic applications. Different classes of immunoglobulin such as IgA, IgG, and IgM are used for the treatment of various neurological and immunological diseases.
Primary factors for the growth of the market are an increase in the geriatric population, an increase in the number of hemophilic patients, enhancement in technology related to immunoglobulin production, and better purification techniques.
North America dominated the market of Intravenous Immunoglobulin (IVIG). Increase in the level of awareness of these procedures and preference of clinicians to adopt these techniques is boosting the growth of the market in this region. Investment in the healthcare system by the government is also propelling the growth of the market.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-intravenous-immunoglobulin-ivig-market
Further key findings from the report suggest
- Human IgG is expressed in the surface of mature B cells and is the most prevalent serum among all the other Immunoglobulin. It held the largest market share of 31% in the year 2018.
- Immunoglobulin via intravenous procedure is majorly done in hospitals. It held a market share of 43% in the year 2018.
- The market is segmented into hospital pharmacy and specialty pharmacy based on the distribution channel.
- Hospital pharmacy is forecast to hold a market share of 58% in the year 2026 with a higher CAGR of 6.5% during the forecast period.
- Hypogammaglobulinemia is an immune disorder that reduces all types of gamma globulins, along with antibodies that help the body fight infection.
- It held the largest market share of 19% in the year 2018. The disease can be from birth, can flare up due to any medication or maybe due to kidney or gastrointestinal condition, severe burns, or cancer.
- Immunodeficiency disease is forecasted to grow with a CAGR of 7.3% during the forecast period. Examples of it can be an infection (HIV), medications (chemotherapy or systemic steroids), and severe burns or malnutrition.
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare disorder where peripheral nerves and nerve roots are inflamed, and myelin sheath over the nerves is destroyed.
- CIDP is growing swiftly with time. It is forecasted to have a CAGR of 6.3% during the forecast period. The disease affects males twice as often as females.
- Kawasaki disease is forecasted to hold a market share of 14% in the year 2026. It is a rare childhood disease that inflames the blood vessels of the body.
- People with the Immune Thrombocytopenic Purpura ITP disease have too few platelets in the blood. It is forecasted to have a CAGR of 8.1% during the forecast period.
- For the purpose of this report, Reports and Data have segmented into the global Intravenous Immunoglobulin (IVIG) Market on the basis of Type, Application, End Users, Distribution Channel, and Region:
Type Outlook (Revenue, USD Billion; 2016-2026)
- IgG
- IgA
- IgM
- IgE
- IgD
Application Outlook (Revenue, USD Billion; 2016-2026)
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Congenital AIDS
- Chronic Inflammatory Demyelinating Polyneuropathy
- Myasthenia Gravis
- Multifocal Motor Neuropathy
- ITP
- Guillain-Barre syndrome
- Kawasaki Diseases
- Others
End Users Outlook (Revenue, USD Billion; 2016-2026)
- Hospitals
- Clinics
- Homecare
- Others
Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)
- Hospital Pharmacy
- Specialty Pharmacy
Regional Outlook (Revenue, USD Billion; 2016-2026)
- North America
- U.S.
- Europe
- UK
- France
- Asia Pacific
- China
- India
- Japan
- MEA
- Latin America
- Brazil
Request for sample of this premium report at:
About Us:
We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.
Contact Us:
John Watson
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
We are a boutique market intelligence and strategic consulting firm dedicated to make an meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum across the globe. Our services are arrayed over diverse sectors and industries looking to expand in alternative regions and products.
Contact Us:
John Watson
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
No comments:
Post a Comment